FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,834 | -48.7% | 60,299 | +15.1% | 0.00% | -100.0% |
| Q2 2023 | $249,343 | +245.8% | 52,383 | +314.1% | 0.00% | – |
| Q1 2023 | $72,099 | -44.0% | 12,649 | 0.0% | 0.00% | – |
| Q4 2022 | $128,640 | -48.1% | 12,649 | +14.4% | 0.00% | -100.0% |
| Q3 2022 | $248,000 | -9.5% | 11,052 | -0.2% | 0.00% | 0.0% |
| Q2 2022 | $274,000 | +26.9% | 11,071 | +99.1% | 0.00% | 0.0% |
| Q1 2022 | $216,000 | -31.4% | 5,560 | +6.3% | 0.00% | 0.0% |
| Q4 2021 | $315,000 | +29.1% | 5,230 | +27.2% | 0.00% | 0.0% |
| Q3 2021 | $244,000 | -31.7% | 4,111 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $357,000 | -39.5% | 4,111 | -42.6% | 0.00% | -50.0% |
| Q1 2021 | $590,000 | +34.4% | 7,158 | +48.1% | 0.00% | +33.3% |
| Q4 2020 | $439,000 | +64.4% | 4,833 | -27.6% | 0.00% | +50.0% |
| Q3 2020 | $267,000 | +16.1% | 6,676 | -0.6% | 0.00% | -33.3% |
| Q2 2020 | $230,000 | -15.4% | 6,718 | -45.2% | 0.00% | -25.0% |
| Q1 2020 | $272,000 | +45.5% | 12,255 | +25.4% | 0.00% | +100.0% |
| Q4 2019 | $187,000 | +54.5% | 9,775 | +25.0% | 0.00% | 0.0% |
| Q3 2019 | $121,000 | -5.5% | 7,820 | +24.3% | 0.00% | 0.0% |
| Q2 2019 | $128,000 | -42.3% | 6,291 | -50.2% | 0.00% | -60.0% |
| Q1 2019 | $222,000 | +47.0% | 12,624 | +9.9% | 0.01% | +25.0% |
| Q4 2018 | $151,000 | -36.6% | 11,485 | -21.3% | 0.00% | -20.0% |
| Q3 2018 | $238,000 | – | 14,601 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |